This document discusses various aspects of assessing and monitoring uveitis, an inflammatory eye condition, through different grading scales and biomarkers. It outlines several methods for clinically grading uveitis based on factors like anterior chamber cells, vitreous haze, and features seen on optical coherence tomography scans like epiretinal membrane thickness and vitreomacular interface changes. Integrity of the ellipsoid zone layer and measurements of choroidal thickness and vascularity are also mentioned as potential biomarkers for monitoring disease activity and treatment response in conditions like choroiditis. Maintaining control of inflammation and addressing comorbidities can help prevent vision loss from uveitic macular edema.
5. Ideal biomarker for uveitis
•reliable.
•noninvasive.
•easy to acquire in routine clinical practice.
•large clinical databases available for validation
10. ERM thickness increase
with uveitis duration
Vitreomacular
interface
3rd
In most eyes with uveitis and ERM, VA remains stable if ocular
inflammation and comorbidities are addressed appropriately.
15. why visual acuity
may not fully
recover to
baseline even
after UME
resolves.
irreversible disruption of retinal neural network and permanent visual acuity loss
16. Seven-year outcomes of uveitic macular edema: the Multicenter Uveitis Steroid Treatment
(MUST) Trial and Follow-up Study results. Ophthalmology. 2021 May ; 128(5): 719–728
each 100-μm reduction in CST = 6.5-letter increase in VA
20-percent reduction in CST should be used as a clinically
meaningful improvement in visual acuity
greater in areas overlying the primary chorioretinal focus.
toxoplasmic retinochoroiditis: round hyper-reflective nodule on the outer face of the focally detached posterior hyaloid(yellow arrow), as well as overlying the retina (green arrow). hyper-reflective full thickness retinal lesion (red asterisk
ERM in IU
VMT in sarcoidosis
COMPLETE PVD
HRF as deposits located within the walls of intraretinal microaneurysms and scattered throughout all retinal layers, forming confluent plaques in the outer plexiform layers.
presence of HRF in the inner and outer retina is associated with worse VA. predict poor treatment response
derangement of the normal laminar inner retinal structure
Foveal DRIL is associated with worse VA at baseline and follow-up visits.Resolution of UME and subretinal fluid occurs after starting treatment. patches of derangement
neurosensory retina has a degree of elasticity Within limits, the continuity of bipolar cells is maintained even with fluid buildup and the connections between the photoreceptor and ganglion cell layers remain viable. if the edema exceeds elastic limits, bipolar axons snap, compromising transmission pathway.
Even in the absence of cystoid spaces and SRF, retinal thickness “Non-cystic thickening,” using the central subfield thickness and perivascular thickening are valuable markers of disease activity on OCT
active birdshot chorioretinopathy FFA:perivascular leakage immunomodulatory treatment
EZ integrity reflects the anatomic arrangement of photoreceptor outer segments
EZ loss with rapid reconstitution after starting penicillin.
intact EZ (arrows) loses its integrity (bracket) within area of UME. mild SRD causing significant EZ disruption
degree of EZ disruption has been associated with intensity of corticosteroid therapy required to treat UME
(i.e., in Vogt-Koyanagi-Harada disease) and for monitoring inflammatory activity.
ratio of vascular area to the total choroidal area
Luminal Area (LA): Area of dark pixels in the choroid Stromal Area (SA): Area of light pixels in the choroid
1 retinitis spare RPE and choroid
2 on top of retina
3 intraretinal and fluid and choroid chorioretinitis
4 protrude from choroid to retina through RPE